Abstract:The fundamental role of the gut mucosal immune system is to maintain tolerance towards luminal antigens and this is achieved through a heavily coordinated and multilayered system of two-way interactions between gut-resident immune cells and molecular signals provided by the microbiome. Mucosal humoral immune responses (and primarily secretory IgA) are a major means by which the host regulates the taxonomic composition [1–7] spatial organization [8–10] and metabolic function of the microbiota [11–13]. One of the most important metabolic functions carried out by commensal microbes is biotransformation of host bile acids (BAs) [14]. BAs are host-derived amphipathic molecules that act as emulsifiers to promote the solubilization and absorption of dietary lipids and lipid-soluble vitamins [15]. BAs are mainly produced in the liver as primary BAs using cholesterol as a precursor and are then transported and stored in the gallbladder until being secreted into the duodenum postprandially. Approximately 95% of all BAs secreted into the gut will be reabsorbed in the distal ileum [16,17]. Under steady-state conditions, the 5% of BAs that escape this recycling process will reach the colon where they are modified by commensal gut bacteria to become secondary BAs. The gut microbiota modifies luminal BA biochemistry through different enzymatic reactions: deconjugation, dehydroxylation, dehydrogenation, epimerization, and oxidation-reduction. The first and rate-limiting step in bacterial BA biotransformation is the cleavage of glycine or taurine from BAs (deconjugation) and this is carried out by bacterial bile salt hydroxylase ( bsh ) enzymes. Bacterial deconjugation of BAs blocks the active transport of BAs through the apical sodium BA transporter (ASBT) [18]. Genetic studies of the human gut microbiota have revealed that members of all major bacterial phyla possess bsh genes and are capable of performing BA deconjugation [19,20]. In contrast to deconjugation, species within several families of the Firmicutes phylum (e.g., Lactobacillaceae, Clostridiaceae, Lachnospiraceae, Ruminococcaceae) appear to be primarily responsible for subsequent enzymatic reactions [21,22]. In addition, intestinal microbiota may regulate the synthesis of BAs in the liver through their ability to directly influence the balance of conjugated BAs in the lumen [23]. Micromolar shifts in the concentrations of hydrophobic BAs can stimulate enterocyte apoptosis [24,25], so enterohepatic circulation of BAs is a tightly regulated process operating through negative feedback mechanisms that maintain physiologically benign BA composition and concentrations. Recently, BAs have been described as signaling molecules that serve as ligands to the nuclear farnesoid X receptor (FXR) and the Takeda G protein-coupled receptor (TGR5) [26]. In addition to their contributions to host metabolism, BAs are also emerging as critical regulators of mucosal immune responses [27–31] with implications in various disease states [32–34]. How BAs promote immune tolerance in the gut, and whether/how the adaptive immune system operates to reinforce this, is an important emerging area of research in mucosal immunology. This review seeks to provide a brief overview of the current state of our knowledge regarding the two-way interaction between BAs and adaptive immunity, with an emphasis on recent work supporting that adaptive (humoral) immunity may serve to reinforce BA-induced immunological tolerance.

Modulation of In Vitro Macrophage Responses via Primary and Secondary Bile Acids in Dogs

Evaluation of Probiotic and Antimicrobial Potential of Canine Derived–<em>Lactobacilli</em>

Inflammatory-Dependent Bidirectional Effect of Bile Acids on NLRP3 Inflammasome and Its Role in Ameliorating CPT-11-Induced Colitis.

Bacterial Community Influences the Effects of Lactobacillus acidophilus on Lipid Metabolism, Immune Response, and Antioxidant Capacity in Dogs

Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis

A reduction of myeloperoxidase and interleukin‐10 expressions in mesenteric lymph nodes of the rats fed a cholic acid‐supplemented diet

The effects of sulfated secondary bile acids on intestinal barrier function and immune response in an inflammatory in vitro human intestinal model

Analysis of the immunomodulatory properties of mycobacterium cell wall fraction on the cytokine production of peripheral blood mononuclear cells of healthy dogs

α-Aminobutyric Acid Constrains Macrophage-Associated Inflammatory Diseases through Metabolic Reprogramming and Epigenetic Modification

The Role of Gut Microbiota-Derived Lithocholic Acid, Deoxycholic Acid and Their Derivatives on the Function and Differentiation of Immune Cells

Molecular Insight into the Response of Lactic Acid Bacteria to Bile Acids

Species Differences of Bile Acid Redox Metabolism: Tertiary Oxidation of Deoxycholate is Conserved in Preclinical Animals.

Bile Acid Derivatives from Gut Microbiota Promote GBPs-mediated Activation of Caspase- 4/11 by LPS Through Lncrna57rik

Characterization of faecal microbiota and serum inflammatory markers in dogs diagnosed with chronic enteropathy or small-cell lymphoma: a pilot study

Microbiota in Mild Inflammatory Bowel Disease (IBD) Can Be Modulated by Beta-Glucans and Mannanoligosaccharides: A Randomized, Double-Blinded Study in Dogs

Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity

Mammalian chemosensory bile acid detection supports species and gut microbiome evaluation

Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model

The interplay between bile acids and mucosal adaptive immunity

Bile Acids Activated Receptors in Inflammatory Bowel Disease

Bile acids induce IL-1α and drive NLRP3 inflammasome-independent production of IL-1β in murine dendritic cells